1. Stents for angina questioned after new study

    Angina? You may NOT need that stent after all!

    Well, it’s officially happened: The mainstream has gone out of its mind!

    It’s now pushing an operation on heart patients that it ADMITS might not work, and it’s using a study it ADMITS is flawed to make the case.

    The reason? Hey, at least patients might get a placebo effect out of it!

    If someone in natural medicine ever made that claim, the mainstream would shut him down faster than you can say “quack.”

    But since this is a mainstream research team pushing an operation that the mainstream already loves, it’s practically applauding.

    The procedure is percutaneous coronary intervention (PCI) for stable angina patients, a.k.a. stenting. It’s incredibly common and is supposed to help ease or eliminate angina pain during exertion such as exercise (in some cases, just climbing the stairs).

    Well, it WAS incredibly common… until last year, when a major study found that it’s no better than a placebo.

    In that study, some patients got the stents, while others went under and THOUGHT they got stents.

    Over six weeks, they had the same benefit.

    The results were so stunning that some doctors stopped doing the operation for these cases.

    Now, a new study by the same team claims that maybe they should climb back aboard the stent wagon.

    On the surface, it certainly LOOKS legit.

    Folks who had the operation got real and measurable benefits. They not only FELT better during exercise and afterward, they had several improvements inside the body, including better blood flow.

    But don’t sign up for a stent yet.

    There are some BIG problems here -- starting with the fact that some of these patients may not have even had angina!

    The previous study used a common one-month evaluation to diagnose the angina patients. In this case, the patients were diagnosed on the spot using an “unvalidated” measure.

    The other study also didn’t use pre-loading of meds. In this one, the patients got both heparin and nitroglycerin.

    And in the other, researchers used a true placebo group of patients who thought they had the operation, but didn’t. In this one, the stent patients were simply compared to people with angina who got nothing at all and knew it.

    That’s just nuts. That means that there could have been a pretty strong placebo effect, and the researchers even ADMIT as much!

    Or maybe it’s a heparin effect.

    Who knows? Not the researchers, because this study wasn’t good enough to sort it out.

    Clearly, stenting can be important in some patients with some conditions. This still doesn’t seem to be one of them, especially when compared to natural therapies such as a sugar-like molecule called D-ribose, which can help angina patients get more activity with less chest pain.

  2. Stents don’t lessen pain in stable angina patients

    Chest pain? Here's what you need to know about stents

    You'd better stand back, because a $15 billion-a-year industry is about to come crashing down!

    A major new study exposes the ugly truth about one of the most common procedures given to heart patients.

    It's an operation that's performed about 1,500 times a day -- a DAY! -- in the United States and Europe. But it turns out that this entire industry is built on assumptions, exaggerations, and flat-out lies.

    And now, even mainstream experts have been forced to admit this common procedure doesn't even work!

    It's called a stent, and I'm sure you know a little something about it.

    You probably know someone who has one. You might even have one yourself.

    During a heart attack, there's no doubt about it: A stent can be a lifesaver.

    But most of them aren't given in emergency, life-or-death situations. They're given to stable angina patients, too.

    The procedure is supposed to improve the flow of blood to the heart and end the chest pain many heart patients with angina feel when they exert themselves or even just go out for a walk.

    Now, the new study changes everything.

    Patients with stable angina and chest pain on exertion were given either a stent or a procedure where they THOUGHT they were getting a stent.

    Six weeks later, BOTH groups improved -- even the folks who had the fake procedure.

    According to scans, the ones who had the operation did have better blood flow, but that didn't translate into better results. They didn't have less pain... they weren't able to tolerate more exertion... and they all had roughly the same improvements in activity levels.

    In other words, this entire operation is nothing more than the placebo effect, at least when it comes to stable angina patients.

    The results are so stunning -- and so conclusive -- that doctors and experts are calling for an immediate change to the guidelines that push stents on stable angina patients. Some docs aren't even waiting for new guidelines. They've said publicly that they're changing how they operate right now based on this study.

    But if you have angina and are struggling with chest pain, it's not enough to do nothing.

    You need a little more help.

    Fortunately, I tackled this very problem last month in Health Revelations -- weeks before this study was published.

    If you're a subscriber, you're already one big step ahead of the rest of the world!

    The answer is a sugar-like molecule called D-ribose, which is proven to help angina patients get more activity with less chest pain.

    If you don't have your October issue handy, don't worry. Use the password in your current edition to get full access online.

    I'll have more cutting-edge news for heart patients coming up later today. Keep an eye on your inbox!

  3. Stents can lead to kidney damage

    What every angioplasty patient needs to know It's a "simple" procedure with dangerous -- even DEADLY -- consequences. And it's not because of the procedure itself. It's because of the DOCTORS who perform it! New research exposes a staggering level of incompetence among many of the docs who perform what's called a percutaneous coronary intervention, or PCI. It's a type...
  4. Flawed study, flawed conclusion

    Researchers speaking in June at the annual meeting of the American Diabetes Association made that bold declaration – saying meds beat out stents for these patients.

4 Item(s)